Drug resistance in cancer cells is a serious complication that is always continuously evolving. Rather than just one or two factors, drug resistance is a combination of a handful of elusive mechanisms. Many of these mechanisms and factors have been studied in the past, however new methods of analysis and treatment are being developed and tested rigorously. Along with new progress and breakthroughs, the pharmaceutical industry must also recognize the increasing expensive cost factor and its burden on cancer patients of the future. Ultimately, new treatment methods accompanied by cost-efficient analysis will provide patients with the best cancer treatment possible.
| Identifer | oai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:OOSHDU.10155/81 |
| Date | 02 March 2010 |
| Creators | Chin, Sean |
| Source Sets | Library and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada |
| Language | English |
| Detected Language | English |
| Type | Article, Research |
Page generated in 0.002 seconds